
Tasha M. Hughes, MD, MPH — Clinical Associate Professor of Surgery; Associate Chair, Department of Surgery, Michigan Medicine / University of Michigan Medical School, USA.
Dr. Hughes is a board-certified surgical oncologist specializing in the treatment of breast cancer and melanoma. She completed her medical degree at Rush Medical College (2010), her general surgery residency at Rush University Medical Center, and a fellowship in Complex General Surgical Oncology at Ohio State University Wexner Medical Center.
Her clinical practice is centered at the Rogel Cancer Center (University of Michigan), where she treats patients with diverse breast pathologies — including DCIS, invasive ductal and lobular carcinoma, inflammatory breast cancer, male breast cancer, and metastatic disease and leads programs such as early detection, sentinel lymph-node biopsy, and lymphedema screening.
In addition to her surgical work, Dr. Hughes is actively engaged in health services research. Her research program focuses on provider-patient communication, implicit and explicit provider bias, healthcare disparities, decision-making in cancer care, patient safety and quality of care. She contributes to both clinical care and academic knowledge, bridging oncology surgery with health policy, equity and quality research. Dr. Hughes is a member of key institutional centers including the Institute for Healthcare Policy & Innovation and the Rogel Cancer Center at Michigan Medicine.
Selected publications from PubMed
Characteristics of Gender-Diverse Patients With Breast Cancer.
Cortina CS, Brazauskas R, Flanagan MR, Dill ED, Joseph KP, Trifonov A, Mukhtar RA, Kim EA, Kantor O, Barmettler G, Rezak KM, Rosenberger LH, Jordan SW, Perez MM, Jimenez RB, Smart AC, Kopkash KA, Hughes TM, Walker JC, Lautner MA, Siegel EL, Brabender DE, Al-Hilli Z, Cassidy MR, Weiss A, McCaffrey RL, Lee MC, Kaoutzanis C, Nguyen KN, Son JD, Williams AD, Madrigrano A, McLaughlin SA, Petroll AE, Stolley M
JAMA Netw Open. 2026 Jul 1;9(7):e2624824 doi: 10.1001/jamanetworkopen.2026.24824.
Evaluating Variation in Lymph Node Sampling During Sentinel Lymph Node Biopsy for Melanoma.
Taylor CD, Niba VS, Baskin AS, Mott NM, Kim E, Kappelman A, Wang T, Sinco BR, Francescatti AB, Boffa DJ, Hendren S, Boughey JC, Hieken TJ, Weigel RJ, Hughes TM, Dossett LA
Ann Surg Oncol. 2025 Dec;32(13):9660-9667 doi: 10.1245/s10434-025-18063-5.
National Variation in Implementation of Sentinel Lymph Node Biopsy for Clinically Node-Positive Patients Undergoing Neoadjuvant Therapy.
Taylor CD, Wang T, Sinco BR, Pilewskie M, Hughes TM, Dossett LA
Ann Surg Oncol. 2025 Jul;32(7):4874-4882 doi: 10.1245/s10434-025-17293-x.
American College of Surgeons Operative Standards and Breast Cancer Outcomes.
Taylor CD, Wang T, Baskin AS, Sinco B, Hughes TM, Boffa DJ, Boughey JC, Dossett LA
JAMA Netw Open. 2024 Nov 4;7(11):e2446345 doi: 10.1001/jamanetworkopen.2024.46345.
Pathological and clinical outcomes following neoadjuvant dual HER2 therapy for early-stage breast cancer: An Australian institutional real-world experience.
Narayanan S, Ngui NK, Kinchington B, Choi JDW, Hughes TMD, Rutovitz J, Hasovits C, Nahar KJ, Edirimanne S, Marx G
Cancer Med. 2024 Jun;13(12):e7325 doi: 10.1002/cam4.7325.
Help your network discover Dr. Tasha M. Hughes's clinical expertise.